0001437749-21-009758.txt : 20210426
0001437749-21-009758.hdr.sgml : 20210426
20210426083215
ACCESSION NUMBER: 0001437749-21-009758
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171231
FILED AS OF DATE: 20210426
DATE AS OF CHANGE: 20210426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tarrabain Alex
CENTRAL INDEX KEY: 0001736937
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55557
FILM NUMBER: 21851663
MAIL ADDRESS:
STREET 1: 18908 89 AVENUE
CITY: EDMONTON
STATE: A0
ZIP: T5T 6B7
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEN BIOTECH INC
CENTRAL INDEX KEY: 0001653821
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
BUSINESS PHONE: 226-344-0660
MAIL ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
5
1
rdgdoc.xml
FORM 5
X0306
5
2017-12-31
0
1
0001653821
CEN BIOTECH INC
CENBF
0001736937
Tarrabain Alex
7405 TECUMSEH ROAD EAST SUITE 300
WINDSOR, ONTARIO, CANADA
A6
N8T 1G2
ONTARIO, CANADA
1
1
Chief Financial Officer*
Common Stock
2017-11-30
4
A
0
L
20000
0
A
69942
D
20,000 shares of common stock of the issuer were granted by the issuer on November 30, 2017, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.
* On July 12, 2017, Alex Tarrabain (the "Reporting Person") was appointed as a director of the issuer. On May 21, 2019, the Reporting Person was appointed as the Chief Financial Officer of the issuer.
/s/ Alex Tarrabain
2021-04-26